Teva Pharmaceuticals Australia Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 1985-06-07 and was issued with the 002951877 ACN. Its Australian Business Number is 98002951877. Since 2014-09-10, the company is headquartered in NSW, post code 2113. The previous headquarters were located in NSW 2113 (from 2009-01-08 to 2014-09-10), NSW 2113 (from 2006-09-19 to 2009-01-08), and NSW 2113 (from 2000-04-06 to 2006-09-19). Teva Pharmaceuticals Australia Pty Ltd was registered for the GST on 2000-07-01. The above data comes from the ABN database which was updated on 2019-01-23. AUBiz found 4 trademarks that mention this company. Trademark number 601917 was filed on 1993-05-07 and is categorised as "word" (application status: "never registered, dead"). Other company trademarks include trademark number 1121833 registered on 2006-07-04 in the "word" category (application status/date: "registered, live", 2006-07-04); and trademark number 1127664 in the "word" category (application status/date: "never registered, dead", 2006-08-02).
Status | From | To |
---|---|---|
Active | April 6, 2000 | current |
Name | From | To |
---|---|---|
Teva Pharmaceuticals Australia Pty Ltd | August 30, 2013 | current |
Cephalon Australia Pty Ltd | February 10, 2010 | August 30, 2013 |
Arana Therapeutics Limited | November 7, 2007 | February 10, 2010 |
Peptech Limited | February 28, 2001 | November 7, 2007 |
Peptech Ltd | April 6, 2000 | February 28, 2001 |
Location | From | To |
---|---|---|
NSW 2113 | September 10, 2014 | current |
NSW 2113 | January 8, 2009 | September 10, 2014 |
NSW 2113 | September 19, 2006 | January 8, 2009 |
NSW 2113 | April 6, 2000 | September 19, 2006 |
Status | From | To |
---|---|---|
Registered | July 1, 2000 | current |
Advertisements
Application date: | May 7, 1993 |
Lodgement date: | May 7, 1993 |
Live or dead: | Dead |
CPI status: | Never Registered |
Status: | Lapsed/Not Protected |
Mark code: | Trade Mark |
Trademark type: | Word |
Acceptance due date: | May 28, 1995 |
Court orders: | No |
Revocation of the acceptance: | No |
Lodgement type: | National |
Descriptive: | Provulin |
Examination report number: | 1 |
Examination class count: | 1 |
NICE class code: | 5 |
NICE occ number: | 1 |
NICE description text: | Veterinary Preparations Including Synthetic Hormones And Especially Synthetic Polypeptide Hormones |
Suburb name: | Dee Why |
Postcode: | 2099 |
Australian state code: | NSW |
Country code: | AU |
Attorney code: | 353306 |
Agency code: | RI |
Transaction type: | Address for service of the trademark |
Suburb name: | Sydney |
Postcode: | 2000 |
Australian state codee: | NSW |
Attorney type: | Attorney |
Country code: | AU |
Application date: | July 4, 2006 |
Lodgement date: | July 4, 2006 |
Registered date: | July 4, 2006 |
Live or dead: | Live |
CPI status: | Registered |
Status: | Registered/Protected |
Mark code: | Trade Mark |
Trademark type: | Word |
Acceptance due date: | October 18, 2006 |
Sealing due date: | May 2, 2007 |
Registered from date: | July 4, 2006 |
Sealing date: | March 6, 2007 |
Renewal due date: | July 4, 2016 |
Court orders: | No |
Revocation of the acceptance: | No |
Lodgement type: | National |
Descriptive: | Synhumanisation |
Examination report number: | 1 |
Examination class count: | 5 |
NICE class code: | 44 |
NICE occ number: | 1 |
NICE description text: | Medical And Veterinarian Services; Medical, Pharmacy And Veterinarian Advice And Consultancy Services; Medical Advice And Information Services For Scientific And Industrial Research |
Suburb name: | Macquarie Park |
Postcode: | 2113 |
Australian state code: | NSW |
Country code: | AU |
Attorney code: | 385395 |
Agency code: | BX |
Transaction type: | Address for service of the trademark |
Suburb name: | Melbourne |
Postcode: | 3000 |
Australian state codee: | VIC |
Attorney type: | Solicitor |
Country code: | AU |
Application date: | August 2, 2006 |
Lodgement date: | August 2, 2006 |
Live or dead: | Dead |
CPI status: | Never Registered |
Status: | Lapsed/Not Protected |
Mark code: | Trade Mark |
Trademark type: | Word |
Acceptance due date: | February 12, 2008 |
Court orders: | No |
Revocation of the acceptance: | No |
Lodgement type: | National |
Descriptive: | Superchimerisation |
Examination report number: | 2 |
Examination class count: | 5 |
NICE class code: | 44 |
NICE occ number: | 1 |
NICE description text: | Medical And Veterinarian Services; Medical, Pharmacy And Veterinarian Advice And Consultancy Services; Medical Advice And Information Services For Scientific And Industrial Research |
Suburb name: | Macquarie Park |
Postcode: | 2113 |
Australian state code: | NSW |
Country code: | AU |
Attorney code: | 385395 |
Agency code: | BX |
Transaction type: | Address for service of the trademark |
Suburb name: | Melbourne |
Postcode: | 3000 |
Australian state codee: | VIC |
Attorney type: | Solicitor |
Country code: | AU |
International Patent Classification:
IPC Mark: | C07K 7/06 |
Section code: | C - chemistrymetallurgy |
Class code: | 7 - organic chemistry |
Subclass code: | K - peptides (peptides containing -lactam rings c07d; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d; ergot alkaloids of the cyclic peptide type c07d0519020000; genetic engineering processes for obtaining peptides c12n0015000000) |
Main group code: | 7 - peptides having 5 to 20 amino acids in a fully defined sequence; derivatives thereof |
Subgroup code: | 6 - having 5 to 11 amino acids |
IP Australia process information:
Expiry date: | March 15, 2011 |
International Patent Classification:
IPC Mark: | C07C 69/734 |
Section code: | C - chemistrymetallurgy |
Class code: | 7 - organic chemistry |
Subclass code: | C - acyclic or carbocyclic compounds (macromolecular compounds c08; production of organic compounds by electrolysis or electrophoresis c25b0003000000, c25b0007000000) |
Main group code: | 69 - esters of carboxylic acids; esters of carbonic or haloformic acids |
Subgroup code: | 734 - ethers |
IP Australia process information:
Expiry date: | October 13, 2015 |
International Patent Classification:
IPC Mark: | A61K 38/04 |
Section code: | A - human necessities |
Class code: | 61 - medical or veterinary science; hygiene |
Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
Main group code: | 38 - medicinal preparations containing peptides (peptides containing beta-lactam rings a61k0031000000; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, a61k0031000000; ergoline-based peptides a61k0031480000; containing macromolecular compounds having statistically distributed amino acid units a61k0031740000; medicinal preparations containing antigens or antibodies a61k0039000000; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, a61k0047000000) |
Subgroup code: | 4 - peptides having up to 20 amino acids in a fully defined sequence; derivatives thereof (gastrins a61k0038160000, somatostatins a61k0038310000, melanotropins a61k0038340000) |
IP Australia process information:
Expiry date: | September 9, 2012 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.